In this study, we tested the hypothesis that deregulation of PELP1 promotes activation of KDM1-driven epigenetic modifications at ERα target genes contributing to cancer proliferation/therapy resistance by testing the therapeutic effect of targeting the PELP1-KDM1 axis. Here, KDM1A is linked to cancer.